跳至主要内容
临床试验/NCT01967355
NCT01967355已完成不适用

Prolongation of Pregnancy in Preeclampsia by Therapeutic Lipid Apheresis

Karl Winkler1 个研究点 分布在 1 个国家目标入组 6 人开始时间: 2013年4月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
6
试验地点
1
主要终点
Prolongation of pregnancy

研究概览

简要总结

Preeclampsia is a disease which occurs in about 6-8% of all pregnancies and is the main cause of maternal and fetal morbidity and mortality. The cause of preeclampsia is still not clear and the only therapy is preterm caesarean section. In severe preeclampsia an accumulation of triglyceride-rich lipoproteins occurs. Therefore, lipid apheresis is performed as lipid-removing therapy for treatment of preeclampsia in order to prolong pregnancy and provide the fetus more time for maturation. In this individual treatment patients with early preeclampsia (<= 32 weeks of gestation) will be offered a H.E.L.P.-apheresis to postpone caesarean section and therefore prolong pregnancy.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者
否

入选标准

  • •pregnant women
  • •early preeclampsia (< 32 week of pregnancy)
  • •arterial hypertension during pregnancy
  • •proteinuria (=> 1 + dipstick or 0> 300 mg/24h)
  • •and/or intrauterine growth retardation (IUGR)
  • •informed consent

排除标准

  • •every acute indication for immediate delivery
  • •no informed consent

研究组 & 干预措施

Lipid apheresis

Experimental

Lipid apheresis: lipid removing therapy,frequency and duration depending on the symptoms of mother and fetus.

干预措施: lipid apheresis (Other)

结局指标

主要结局

Prolongation of pregnancy

时间窗: Mother will be followed up for the duration of hospital stay, that is from first lipid apheresis until the discharge of the mother in the days following birth (an expected average of 3-4 weeks).

A deteriorating clinical condition of the mother and the fetus necessitates a caesarean section (c.s.). However, if c.s. takes place too early lung maturation of the fetus may not be completed. Apheresis is initiated and will be continued until lung maturity is achieved and the clinical condition of the mother and the fetus improves.

次要结局

  • Reduction of lipoprotein levels(Mother will be followed up for the duration of hospital stay, that is from first lipid apheresis until the discharge of the mother in the days following birth (an expected average of 3-4 weeks).)

研究者

发起方
Karl Winkler
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Karl Winkler

Professor Dr. med.

University Hospital Freiburg

研究点 (1)

Loading locations...

相似试验